Numinus Wellness Inc.
NUMIF
$0.035
$0.007225.90%
| 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.89M | 16.51M | 16.74M | 16.59M | 15.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.89M | 16.51M | 16.74M | 16.59M | 15.23M |
| Cost of Revenue | 8.51M | 8.46M | 8.46M | 8.12M | 7.10M |
| Gross Profit | 3.63M | 4.31M | 4.31M | 4.49M | 4.16M |
| SG&A Expenses | 12.81M | 15.26M | 15.26M | 17.01M | 19.51M |
| Depreciation & Amortization | 743.80K | 834.50K | 834.50K | 886.70K | 1.10M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.73M | 32.41M | 34.14M | 35.91M | 37.89M |
| Operating Income | -13.84M | -15.90M | -17.40M | -19.32M | -22.66M |
| Income Before Tax | -14.03M | -15.36M | -15.36M | -16.80M | -28.93M |
| Income Tax Expenses | -36.00K | -29.10K | -29.10K | -29.10K | -19.50K |
| Earnings from Continuing Operations | -13.99 | -15.33 | -15.33 | -16.78 | -28.91 |
| Earnings from Discontinued Operations | -463.30K | -275.10K | -275.10K | -275.10K | -275.10K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.89M | -20.04M | -21.04M | -22.48M | -34.62M |
| EBIT | -13.84M | -15.90M | -17.40M | -19.32M | -22.66M |
| EBITDA | -13.39M | -15.03M | -16.12M | -17.66M | -20.98M |
| EPS Basic | -0.07 | -0.08 | -0.09 | -0.09 | -0.15 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.04 | -0.05 |
| EPS Diluted | -0.07 | -0.08 | -0.09 | -0.09 | -0.15 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 1.08B | 1.03B | 1.03B | 1.03B | 975.75M |
| Average Diluted Shares Outstanding | 1.08B | 1.03B | 1.03B | 1.03B | 975.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
